Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Whitbread Share News (WTB)
WTB Share
Price
WTB Share
News
WTB Share
Chat
WTB Share
Trades470
WTB
Live RNS
WTB Share
Charts
WTB Level 2
Console
WTB Live
Share Price
WTB Broker
Ratings
WTB Directors
Deals
WTB Financial
Diary
WTB
Fundamentals
WTB Short
Positions5
WTB
Media
WTB Company
Research
WTB Company
Timeline5
Whitbread Information
Share Price Information for Whitbread (WTB)
Share Price is delayed by 15 minutes
Get Live Data
2,330.00
0.00 (0.00%)
Bid:
2,329.00
Ask:
2,331.00
Spread:
2.00 (0.086%)
Market Cap:
£3.89b
Last checked at -
Last checked at 
Intraday Whitbread Share Chart
Whitbread News
25 Nov 2020
UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore
UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore
20 Nov 2020
IN BRIEF: Schroder Income Growth Lags Benchmark; Three Main Detractors
IN BRIEF: Schroder Income Growth Lags Benchmark; Three Main Detractors
19 Nov 2020
LONDON MARKET OPEN: NY Restrictions And Japan Virus Alert Damp Spirits
LONDON MARKET OPEN: NY Restrictions And Japan Virus Alert Damp Spirits
18 Nov 2020
UK BROKER RATINGS SUMMARY: UBS And Goldman Both Cut Compass To Neutral
UK BROKER RATINGS SUMMARY: UBS And Goldman Both Cut Compass To Neutral
17 Nov 2020
DIRECTOR DEALINGS: Alison Brittain Buys Shares After Experian Results
DIRECTOR DEALINGS: Alison Brittain Buys Shares After Experian Results
16 Nov 2020
LONDON MARKET CLOSE: Moderna Covid Vaccine Injects Life Into Markets
LONDON MARKET CLOSE: Moderna Covid Vaccine Injects Life Into Markets
16 Nov 2020
Moderna reports 95% efficacy in Covid vaccine trials, stocks jump
(Sharecast News) - Markets rallied on Monday after US biotech Moderna said its experimental Covid-19 vaccine had proved nearly 95% effective in phase ...
16 Nov 2020
LONDON MARKET MIDDAY: Momentum Continues On Vaccine Hopes, Upbeat Data
LONDON MARKET MIDDAY: Momentum Continues On Vaccine Hopes, Upbeat Data
Follow the stocks
